COVID-19-Associated Bronchiectasis and Its Impact on Prognosis.

Autor:	Suliman AM; Internal Medicine Department, Hamad Medical Corporation, Doha, QAT., Bitar BW; Internal Medicine Department, Hamad Medical Corporation, Doha, QAT., Farooqi AA; Internal Medicine Department, Hamad Medical Corporation, Doha, QAT., Elarabi AM; Pulmonology Department, Hamad Medical Corporation, Doha, QAT., Aboukamar MR; Infectious Disease Department, Hamad Medical Corporation, Doha, QAT., Abdulhadi AS; Internal Medicine Department, Hamad Medical Corporation, Doha, QAT.
Jazyk:	angličtina
Zdroj:	Cureus [Cureus] 2021 May 16; Vol. 13 (5), pp. e15051. Date of Electronic Publication: 2021 May 16.
DOI:	10.7759/cureus.15051
Abstrakt:	Coronavirus disease 2019 (COVID-19), which initially emerged in Wuhan, China, has rapidly swept around the world, causing grave morbidity and mortality. It manifests with several symptoms, on a spectrum from asymptomatic to severe illness and death. Many typical imaging features of this disease are described, such as bilateral multi-lobar ground-glass opacities (GGO) or consolidations with a predominantly peripheral distribution. COVID-19-associated bronchiectasis is an atypical finding, and it is not a commonly described sequel of the disease. Here, we present a previously healthy middle-aged man who developed progressive bronchiectasis evident on serial chest CT scans with superimposed bacterial infection following COVID-19 pneumonia. The patient's complicated hospital course of superimposed bacterial infection in the setting of presumed bronchiectasis secondary to COVID-19 is alleged to have contributed to his prolonged hospital stay, with difficulty in weaning off mechanical ventilation. Clinicians should have high suspicion and awareness of such a debilitating complication, as further follow-up and management might be warranted. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2021, Suliman et al.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu